DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 016267
The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Summary for 016267
Tradename: | DESFERAL |
Applicant: | Novartis |
Ingredient: | deferoxamine mesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 016267
Mechanism of Action | Iron Chelating Activity |
Medical Subject Heading (MeSH) Categories for 016267
Suppliers and Packaging for NDA: 016267
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DESFERAL | deferoxamine mesylate | INJECTABLE;INJECTION | 016267 | NDA | Novartis Pharmaceuticals Corporation | 0078-0467 | N | 0078-0467-91 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/VIAL | ||||
Approval Date: | May 25, 2000 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 016267
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | DESFERAL | deferoxamine mesylate | INJECTABLE;INJECTION | 016267-001 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription